nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—head and neck cancer—esophageal cancer	0.811	1	CtDrD
Hydroxyurea—RRM1—larynx—esophageal cancer	0.0113	0.428	CbGeAlD
Hydroxyurea—Dermatitis radiation NOS—Methotrexate—esophageal cancer	0.00937	0.0893	CcSEcCtD
Hydroxyurea—Radiation skin injury—Methotrexate—esophageal cancer	0.00937	0.0893	CcSEcCtD
Hydroxyurea—Leg ulcer—Capecitabine—esophageal cancer	0.00723	0.0689	CcSEcCtD
Hydroxyurea—Urine output—Cisplatin—esophageal cancer	0.00341	0.0325	CcSEcCtD
Hydroxyurea—Metastatic neoplasm—Cisplatin—esophageal cancer	0.00308	0.0294	CcSEcCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00302	0.0518	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.00253	0.0434	CbGpPWpGaD
Hydroxyurea—Recall phenomenon—Capecitabine—esophageal cancer	0.00251	0.0239	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00249	0.0427	CbGpPWpGaD
Hydroxyurea—RRM2—bronchus—esophageal cancer	0.00241	0.0916	CbGeAlD
Hydroxyurea—Azoospermia—Cisplatin—esophageal cancer	0.00219	0.0209	CcSEcCtD
Hydroxyurea—Gastrointestinal ulcer—Methotrexate—esophageal cancer	0.0021	0.02	CcSEcCtD
Hydroxyurea—Hepatic insufficiency—Methotrexate—esophageal cancer	0.0021	0.02	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.00209	0.0358	CbGpPWpGaD
Hydroxyurea—Fibrosis—Cisplatin—esophageal cancer	0.00207	0.0197	CcSEcCtD
Hydroxyurea—RRM1—bronchus—esophageal cancer	0.002	0.0761	CbGeAlD
Hydroxyurea—Ureteric obstruction—Methotrexate—esophageal cancer	0.00198	0.0188	CcSEcCtD
Hydroxyurea—RRM1—smooth muscle tissue—esophageal cancer	0.00196	0.0745	CbGeAlD
Hydroxyurea—Urine output—Methotrexate—esophageal cancer	0.00187	0.0178	CcSEcCtD
Hydroxyurea—RRM2—digestive system—esophageal cancer	0.00186	0.0708	CbGeAlD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.00176	0.0301	CbGpPWpGaD
Hydroxyurea—Skin necrosis—Cisplatin—esophageal cancer	0.00169	0.0161	CcSEcCtD
Hydroxyurea—RRM2—lung—esophageal cancer	0.00155	0.0591	CbGeAlD
Hydroxyurea—Oligospermia—Methotrexate—esophageal cancer	0.00155	0.0148	CcSEcCtD
Hydroxyurea—RRM1—digestive system—esophageal cancer	0.00154	0.0588	CbGeAlD
Hydroxyurea—Fibrosis—Capecitabine—esophageal cancer	0.00152	0.0145	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.00145	0.0248	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.00143	0.0245	CbGpPWpGaD
Hydroxyurea—Anaemia megaloblastic—Methotrexate—esophageal cancer	0.00138	0.0131	CcSEcCtD
Hydroxyurea—RRM1—lung—esophageal cancer	0.00129	0.0491	CbGeAlD
Hydroxyurea—RRM1—Nucleotide metabolism—TYMP—esophageal cancer	0.00127	0.0218	CbGpPWpGaD
Hydroxyurea—Myelosuppression—Cisplatin—esophageal cancer	0.00126	0.012	CcSEcCtD
Hydroxyurea—Azoospermia—Methotrexate—esophageal cancer	0.0012	0.0115	CcSEcCtD
Hydroxyurea—Leukaemia—Methotrexate—esophageal cancer	0.0012	0.0115	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.00118	0.0202	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—XRCC1—esophageal cancer	0.00116	0.02	CbGpPWpGaD
Hydroxyurea—Fibrosis—Methotrexate—esophageal cancer	0.00113	0.0108	CcSEcCtD
Hydroxyurea—CYP2D6—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00107	0.0184	CbGpPWpGaD
Hydroxyurea—RRM2—lymph node—esophageal cancer	0.00106	0.0404	CbGeAlD
Hydroxyurea—RRM2—Nucleotide metabolism—TYMP—esophageal cancer	0.00105	0.018	CbGpPWpGaD
Hydroxyurea—Febrile neutropenia—Cisplatin—esophageal cancer	0.000982	0.00936	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—XRCC1—esophageal cancer	0.000958	0.0164	CbGpPWpGaD
Hydroxyurea—Skin necrosis—Methotrexate—esophageal cancer	0.000928	0.00885	CcSEcCtD
Hydroxyurea—RRM1—lymph node—esophageal cancer	0.000882	0.0336	CbGeAlD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.000846	0.0145	CbGpPWpGaD
Hydroxyurea—Mucosal inflammation—Capecitabine—esophageal cancer	0.000787	0.0075	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Cisplatin—esophageal cancer	0.000765	0.0073	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000759	0.013	CbGpPWpGaD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.000742	0.0127	CbGpPWpGaD
Hydroxyurea—Pulmonary fibrosis—Methotrexate—esophageal cancer	0.000737	0.00703	CcSEcCtD
Hydroxyurea—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.000732	0.00698	CcSEcCtD
Hydroxyurea—Platelet count decreased—Capecitabine—esophageal cancer	0.000732	0.00698	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Capecitabine—esophageal cancer	0.000724	0.0069	CcSEcCtD
Hydroxyurea—Infection—Carboplatin—esophageal cancer	0.000714	0.00681	CcSEcCtD
Hydroxyurea—Lung infiltration—Methotrexate—esophageal cancer	0.000691	0.00659	CcSEcCtD
Hydroxyurea—Hypomagnesaemia—Capecitabine—esophageal cancer	0.000686	0.00654	CcSEcCtD
Hydroxyurea—Tenderness—Cisplatin—esophageal cancer	0.000677	0.00646	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—HMGB1—esophageal cancer	0.00067	0.0115	CbGpPWpGaD
Hydroxyurea—CYP2D6—CYP2E1 reactions—CYP2A6—esophageal cancer	0.000663	0.0114	CbGpPWpGaD
Hydroxyurea—Bone marrow depression—Capecitabine—esophageal cancer	0.000645	0.00615	CcSEcCtD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—RB1—esophageal cancer	0.000639	0.011	CbGpPWpGaD
Hydroxyurea—Hyperuricaemia—Cisplatin—esophageal cancer	0.000637	0.00607	CcSEcCtD
Hydroxyurea—Ulcer—Cisplatin—esophageal cancer	0.000625	0.00596	CcSEcCtD
Hydroxyurea—Pain—Carboplatin—esophageal cancer	0.000615	0.00586	CcSEcCtD
Hydroxyurea—Blister—Capecitabine—esophageal cancer	0.000604	0.00576	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Cisplatin—esophageal cancer	0.000602	0.00574	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000589	0.0101	CbGpPWpGaD
Hydroxyurea—Mucosal inflammation—Methotrexate—esophageal cancer	0.000586	0.00558	CcSEcCtD
Hydroxyurea—Body temperature increased—Carboplatin—esophageal cancer	0.000568	0.00542	CcSEcCtD
Hydroxyurea—CYP2D6—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.000568	0.00974	CbGpPWpGaD
Hydroxyurea—Skin exfoliation—Cisplatin—esophageal cancer	0.000564	0.00538	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Capecitabine—esophageal cancer	0.000564	0.00538	CcSEcCtD
Hydroxyurea—Skin ulcer—Capecitabine—esophageal cancer	0.000559	0.00533	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—ABL1—esophageal cancer	0.000554	0.0095	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—HMGB1—esophageal cancer	0.000551	0.00946	CbGpPWpGaD
Hydroxyurea—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.000545	0.0052	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Methotrexate—esophageal cancer	0.000539	0.00514	CcSEcCtD
Hydroxyurea—Eruption—Methotrexate—esophageal cancer	0.000527	0.00503	CcSEcCtD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.000523	0.00897	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—PSME2—esophageal cancer	0.000519	0.00891	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—PSME1—esophageal cancer	0.000519	0.00891	CbGpPWpGaD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.000491	0.00843	CbGpPWpGaD
Hydroxyurea—Bone marrow depression—Methotrexate—esophageal cancer	0.00048	0.00458	CcSEcCtD
Hydroxyurea—Renal failure acute—Cisplatin—esophageal cancer	0.000465	0.00443	CcSEcCtD
Hydroxyurea—Ulcer—Capecitabine—esophageal cancer	0.00046	0.00439	CcSEcCtD
Hydroxyurea—CYP2D6—digestive system—esophageal cancer	0.000459	0.0175	CbGeAlD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—ABL1—esophageal cancer	0.000456	0.00783	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PSME1—esophageal cancer	0.000437	0.0075	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PSME2—esophageal cancer	0.000437	0.0075	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—AJUBA—esophageal cancer	0.000431	0.0074	CbGpPWpGaD
Hydroxyurea—Hepatotoxicity—Methotrexate—esophageal cancer	0.00042	0.004	CcSEcCtD
Hydroxyurea—Skin ulcer—Methotrexate—esophageal cancer	0.000416	0.00397	CcSEcCtD
Hydroxyurea—Skin exfoliation—Capecitabine—esophageal cancer	0.000416	0.00396	CcSEcCtD
Hydroxyurea—Face oedema—Cisplatin—esophageal cancer	0.000414	0.00395	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—CREBBP—esophageal cancer	0.000413	0.00708	CbGpPWpGaD
Hydroxyurea—CYP2D6—Xenobiotics—CYP2A6—esophageal cancer	0.000411	0.00705	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RB1—esophageal cancer	0.000411	0.00705	CbGpPWpGaD
Hydroxyurea—Blood creatinine increased—Cisplatin—esophageal cancer	0.000402	0.00383	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000401	0.00687	CbGpPWpGaD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.000395	0.00678	CbGpPWpGaD
Hydroxyurea—Neoplasm—Capecitabine—esophageal cancer	0.000394	0.00375	CcSEcCtD
Hydroxyurea—Breast disorder—Cisplatin—esophageal cancer	0.000388	0.0037	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—AJUBA—esophageal cancer	0.000386	0.00662	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—esophageal cancer	0.00038	0.00651	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000366	0.00628	CbGpPWpGaD
Hydroxyurea—Pancreatitis—Cisplatin—esophageal cancer	0.000363	0.00347	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—esophageal cancer	0.000361	0.0062	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RB1—esophageal cancer	0.000357	0.00613	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Cisplatin—esophageal cancer	0.000352	0.00336	CcSEcCtD
Hydroxyurea—Hepatic failure—Capecitabine—esophageal cancer	0.000352	0.00335	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Methotrexate—esophageal cancer	0.00035	0.00333	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MLH3—esophageal cancer	0.000349	0.00598	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000348	0.00598	CbGpPWpGaD
Hydroxyurea—Ulcer—Methotrexate—esophageal cancer	0.000343	0.00327	CcSEcCtD
Hydroxyurea—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000343	0.00327	CcSEcCtD
Hydroxyurea—Renal failure acute—Capecitabine—esophageal cancer	0.000342	0.00327	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—CREBBP—esophageal cancer	0.00034	0.00583	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—RB1—esophageal cancer	0.000338	0.00581	CbGpPWpGaD
Hydroxyurea—Dermatitis bullous—Capecitabine—esophageal cancer	0.000331	0.00315	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Methotrexate—esophageal cancer	0.00033	0.00315	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000324	0.00309	CcSEcCtD
Hydroxyurea—Stomatitis—Cisplatin—esophageal cancer	0.000322	0.00307	CcSEcCtD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000319	0.00547	CbGpPWpGaD
Hydroxyurea—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000313	0.00298	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000313	0.00536	CbGpPWpGaD
Hydroxyurea—Skin exfoliation—Methotrexate—esophageal cancer	0.00031	0.00295	CcSEcCtD
Hydroxyurea—Face oedema—Capecitabine—esophageal cancer	0.000305	0.00291	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—esophageal cancer	0.000298	0.0051	CbGpPWpGaD
Hydroxyurea—Blood creatinine increased—Capecitabine—esophageal cancer	0.000296	0.00282	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN1A—esophageal cancer	0.000295	0.00507	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000295	0.00507	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RB1—esophageal cancer	0.000294	0.00505	CbGpPWpGaD
Hydroxyurea—Neoplasm—Methotrexate—esophageal cancer	0.000293	0.0028	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Methotrexate—esophageal cancer	0.000289	0.00275	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000286	0.00491	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000286	0.00491	CbGpPWpGaD
Hydroxyurea—Breast disorder—Capecitabine—esophageal cancer	0.000286	0.00272	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—EP300—esophageal cancer	0.000281	0.00482	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000271	0.00464	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.000265	0.00455	CbGpPWpGaD
Hydroxyurea—Alopecia—Cisplatin—esophageal cancer	0.000262	0.0025	CcSEcCtD
Hydroxyurea—Hepatic failure—Methotrexate—esophageal cancer	0.000262	0.0025	CcSEcCtD
Hydroxyurea—Pancytopenia—Capecitabine—esophageal cancer	0.00026	0.00247	CcSEcCtD
Hydroxyurea—Erythema—Cisplatin—esophageal cancer	0.000258	0.00246	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000257	0.0044	CbGpPWpGaD
Hydroxyurea—Dysuria—Capecitabine—esophageal cancer	0.000256	0.00244	CcSEcCtD
Hydroxyurea—Neutropenia—Capecitabine—esophageal cancer	0.000256	0.00244	CcSEcCtD
Hydroxyurea—Renal failure acute—Methotrexate—esophageal cancer	0.000255	0.00243	CcSEcCtD
Hydroxyurea—Weight increased—Capecitabine—esophageal cancer	0.000249	0.00237	CcSEcCtD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.000246	0.00422	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—RB1—esophageal cancer	0.000246	0.00421	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—esophageal cancer	0.000245	0.0042	CbGpPWpGaD
Hydroxyurea—Infestation—Capecitabine—esophageal cancer	0.000244	0.00232	CcSEcCtD
Hydroxyurea—Infestation NOS—Capecitabine—esophageal cancer	0.000244	0.00232	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN1A—esophageal cancer	0.000243	0.00417	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Cisplatin—esophageal cancer	0.00024	0.00229	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00024	0.00411	CbGpPWpGaD
Hydroxyurea—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000239	0.00228	CcSEcCtD
Hydroxyurea—Anaemia—Cisplatin—esophageal cancer	0.000239	0.00228	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000238	0.00409	CbGpPWpGaD
Hydroxyurea—Stomatitis—Capecitabine—esophageal cancer	0.000237	0.00226	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000236	0.00406	CbGpPWpGaD
Hydroxyurea—Malaise—Cisplatin—esophageal cancer	0.000233	0.00222	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—EP300—esophageal cancer	0.000231	0.00397	CbGpPWpGaD
Hydroxyurea—Leukopenia—Cisplatin—esophageal cancer	0.000231	0.0022	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00023	0.0022	CcSEcCtD
Hydroxyurea—Convulsion—Cisplatin—esophageal cancer	0.000224	0.00213	CcSEcCtD
Hydroxyurea—Haemoglobin—Capecitabine—esophageal cancer	0.00022	0.0021	CcSEcCtD
Hydroxyurea—Haemorrhage—Capecitabine—esophageal cancer	0.000219	0.00209	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.000218	0.00375	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000218	0.00208	CcSEcCtD
Hydroxyurea—Discomfort—Cisplatin—esophageal cancer	0.000217	0.00207	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	0.000213	0.00365	CbGpPWpGaD
Hydroxyurea—Breast disorder—Methotrexate—esophageal cancer	0.000213	0.00203	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000211	0.00363	CbGpPWpGaD
Hydroxyurea—Oedema—Cisplatin—esophageal cancer	0.000211	0.00201	CcSEcCtD
Hydroxyurea—Infection—Cisplatin—esophageal cancer	0.000209	0.002	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000209	0.00358	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—RB1—esophageal cancer	0.000207	0.00355	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.000207	0.00355	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Cisplatin—esophageal cancer	0.000207	0.00197	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Cisplatin—esophageal cancer	0.000206	0.00197	CcSEcCtD
Hydroxyurea—Skin disorder—Cisplatin—esophageal cancer	0.000205	0.00195	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—esophageal cancer	0.000202	0.00346	CbGpPWpGaD
Hydroxyurea—Anorexia—Cisplatin—esophageal cancer	0.000201	0.00192	CcSEcCtD
Hydroxyurea—Pancreatitis—Methotrexate—esophageal cancer	0.000199	0.0019	CcSEcCtD
Hydroxyurea—Angiopathy—Capecitabine—esophageal cancer	0.000198	0.00189	CcSEcCtD
Hydroxyurea—Chills—Capecitabine—esophageal cancer	0.000196	0.00187	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000194	0.00333	CbGpPWpGaD
Hydroxyurea—Alopecia—Capecitabine—esophageal cancer	0.000193	0.00184	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—esophageal cancer	0.000193	0.00184	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000192	0.00329	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000191	0.00328	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—BLVRB—esophageal cancer	0.000191	0.00327	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC52A3—esophageal cancer	0.000191	0.00327	CbGpPWpGaD
Hydroxyurea—Erythema—Capecitabine—esophageal cancer	0.00019	0.00182	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—esophageal cancer	0.00019	0.00181	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—esophageal cancer	0.00019	0.00181	CcSEcCtD
Hydroxyurea—Dyspnoea—Cisplatin—esophageal cancer	0.000188	0.00179	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—HIST1H2BM—esophageal cancer	0.000185	0.00317	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Cisplatin—esophageal cancer	0.000183	0.00175	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.000183	0.00313	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000182	0.00174	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—esophageal cancer	0.000182	0.00312	CbGpPWpGaD
Hydroxyurea—Infestation NOS—Methotrexate—esophageal cancer	0.000181	0.00173	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—esophageal cancer	0.000181	0.00173	CcSEcCtD
Hydroxyurea—Drowsiness—Methotrexate—esophageal cancer	0.000181	0.00173	CcSEcCtD
Hydroxyurea—Pain—Cisplatin—esophageal cancer	0.00018	0.00172	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—esophageal cancer	0.000177	0.00169	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Capecitabine—esophageal cancer	0.000177	0.00168	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CDKN1A—esophageal cancer	0.000176	0.00303	CbGpPWpGaD
Hydroxyurea—Anaemia—Capecitabine—esophageal cancer	0.000176	0.00168	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	0.000175	0.00301	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	0.000175	0.003	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Cisplatin—esophageal cancer	0.000174	0.00166	CcSEcCtD
Hydroxyurea—Malaise—Capecitabine—esophageal cancer	0.000172	0.00164	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000172	0.00164	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000171	0.00293	CbGpPWpGaD
Hydroxyurea—Leukopenia—Capecitabine—esophageal cancer	0.00017	0.00163	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000168	0.00289	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Cisplatin—esophageal cancer	0.000167	0.00159	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000165	0.00283	CbGpPWpGaD
Hydroxyurea—Haemoglobin—Methotrexate—esophageal cancer	0.000164	0.00156	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MAD2L1—esophageal cancer	0.000163	0.0028	CbGpPWpGaD
Hydroxyurea—Haemorrhage—Methotrexate—esophageal cancer	0.000163	0.00155	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CA1—esophageal cancer	0.000162	0.00278	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC10A2—esophageal cancer	0.000162	0.00278	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000161	0.00153	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.00016	0.00275	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.00016	0.00275	CbGpPWpGaD
Hydroxyurea—Discomfort—Capecitabine—esophageal cancer	0.00016	0.00153	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.00016	0.00275	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—BLVRB—esophageal cancer	0.000157	0.0027	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC52A3—esophageal cancer	0.000157	0.0027	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000157	0.00268	CbGpPWpGaD
Hydroxyurea—Oedema—Capecitabine—esophageal cancer	0.000155	0.00148	CcSEcCtD
Hydroxyurea—Hypersensitivity—Cisplatin—esophageal cancer	0.000155	0.00148	CcSEcCtD
Hydroxyurea—Infection—Capecitabine—esophageal cancer	0.000154	0.00147	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND1—esophageal cancer	0.000154	0.00264	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Capecitabine—esophageal cancer	0.000152	0.00145	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Capecitabine—esophageal cancer	0.000152	0.00145	CcSEcCtD
Hydroxyurea—Asthenia—Cisplatin—esophageal cancer	0.000151	0.00144	CcSEcCtD
Hydroxyurea—Skin disorder—Capecitabine—esophageal cancer	0.000151	0.00144	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1A—esophageal cancer	0.000149	0.00255	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CA2—esophageal cancer	0.000148	0.00255	CbGpPWpGaD
Hydroxyurea—Anorexia—Capecitabine—esophageal cancer	0.000148	0.00141	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—esophageal cancer	0.000148	0.00141	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000147	0.00252	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—MYC—esophageal cancer	0.000146	0.00251	CbGpPWpGaD
Hydroxyurea—Chills—Methotrexate—esophageal cancer	0.000146	0.00139	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.000146	0.00251	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Cisplatin—esophageal cancer	0.000144	0.00138	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	0.000144	0.00247	CbGpPWpGaD
Hydroxyurea—Alopecia—Methotrexate—esophageal cancer	0.000144	0.00137	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—PSME1—esophageal cancer	0.000143	0.00246	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PSME2—esophageal cancer	0.000143	0.00246	CbGpPWpGaD
Hydroxyurea—Erythema—Methotrexate—esophageal cancer	0.000142	0.00135	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000141	0.00243	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Capecitabine—esophageal cancer	0.000139	0.00132	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000138	0.00237	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PLCE1—esophageal cancer	0.000138	0.00237	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ADH7—esophageal cancer	0.000138	0.00237	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000138	0.00236	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000137	0.00235	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Capecitabine—esophageal cancer	0.000137	0.0013	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000136	0.00233	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Capecitabine—esophageal cancer	0.000135	0.00129	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000134	0.00128	CcSEcCtD
Hydroxyurea—Vomiting—Cisplatin—esophageal cancer	0.000134	0.00128	CcSEcCtD
Hydroxyurea—Fatigue—Capecitabine—esophageal cancer	0.000134	0.00128	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CA1—esophageal cancer	0.000134	0.00229	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC10A2—esophageal cancer	0.000134	0.00229	CbGpPWpGaD
Hydroxyurea—Rash—Cisplatin—esophageal cancer	0.000133	0.00127	CcSEcCtD
Hydroxyurea—Pain—Capecitabine—esophageal cancer	0.000133	0.00127	CcSEcCtD
Hydroxyurea—Constipation—Capecitabine—esophageal cancer	0.000133	0.00127	CcSEcCtD
Hydroxyurea—Dermatitis—Cisplatin—esophageal cancer	0.000133	0.00127	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—esophageal cancer	0.000132	0.00125	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000131	0.00225	CbGpPWpGaD
Hydroxyurea—Anaemia—Methotrexate—esophageal cancer	0.000131	0.00125	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—BUB1B—esophageal cancer	0.000131	0.00224	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.00013	0.00223	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000129	0.00222	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Capecitabine—esophageal cancer	0.000128	0.00122	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—esophageal cancer	0.000128	0.00122	CcSEcCtD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000128	0.00219	CbGpPWpGaD
Hydroxyurea—Leukopenia—Methotrexate—esophageal cancer	0.000127	0.00121	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.000127	0.00217	CbGpPWpGaD
Hydroxyurea—Nausea—Cisplatin—esophageal cancer	0.000125	0.00119	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CHEK2—esophageal cancer	0.000124	0.00213	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—esophageal cancer	0.000123	0.00212	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Capecitabine—esophageal cancer	0.000123	0.00117	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—esophageal cancer	0.000123	0.00117	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CA2—esophageal cancer	0.000122	0.0021	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ADH1B—esophageal cancer	0.000121	0.00207	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00012	0.00114	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—esophageal cancer	0.000119	0.00114	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—TYMP—esophageal cancer	0.000116	0.00198	CbGpPWpGaD
Hydroxyurea—Infection—Methotrexate—esophageal cancer	0.000115	0.0011	CcSEcCtD
Hydroxyurea—Hypersensitivity—Capecitabine—esophageal cancer	0.000114	0.00109	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PLCE1—esophageal cancer	0.000114	0.00195	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ADH7—esophageal cancer	0.000114	0.00195	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Methotrexate—esophageal cancer	0.000113	0.00108	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000113	0.00195	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Methotrexate—esophageal cancer	0.000113	0.00108	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP26A1—esophageal cancer	0.000112	0.00193	CbGpPWpGaD
Hydroxyurea—Skin disorder—Methotrexate—esophageal cancer	0.000112	0.00107	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000112	0.00191	CbGpPWpGaD
Hydroxyurea—Asthenia—Capecitabine—esophageal cancer	0.000111	0.00106	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.000111	0.0019	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000111	0.0019	CbGpPWpGaD
Hydroxyurea—Anorexia—Methotrexate—esophageal cancer	0.00011	0.00105	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ALOX15—esophageal cancer	0.00011	0.00188	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Capecitabine—esophageal cancer	0.000106	0.00101	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000105	0.0018	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—TPI1—esophageal cancer	0.000105	0.00179	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTO1—esophageal cancer	0.000105	0.00179	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.000103	0.00177	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Methotrexate—esophageal cancer	0.000103	0.000983	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—esophageal cancer	0.000103	0.000981	CcSEcCtD
Hydroxyurea—Dizziness—Capecitabine—esophageal cancer	0.000103	0.00098	CcSEcCtD
Hydroxyurea—Dyspepsia—Methotrexate—esophageal cancer	0.000102	0.000971	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000102	0.00175	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Methotrexate—esophageal cancer	0.000101	0.000959	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ALDOB—esophageal cancer	0.0001	0.00172	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—esophageal cancer	9.99e-05	0.000952	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—esophageal cancer	9.97e-05	0.000951	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ADH1B—esophageal cancer	9.96e-05	0.00171	CbGpPWpGaD
Hydroxyurea—Pain—Methotrexate—esophageal cancer	9.89e-05	0.000943	CcSEcCtD
Hydroxyurea—Vomiting—Capecitabine—esophageal cancer	9.88e-05	0.000942	CcSEcCtD
Hydroxyurea—Rash—Capecitabine—esophageal cancer	9.8e-05	0.000934	CcSEcCtD
Hydroxyurea—Dermatitis—Capecitabine—esophageal cancer	9.79e-05	0.000933	CcSEcCtD
Hydroxyurea—Headache—Capecitabine—esophageal cancer	9.74e-05	0.000928	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GAPDH—esophageal cancer	9.65e-05	0.00165	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	9.63e-05	0.00165	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	9.59e-05	0.00165	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CRABP1—esophageal cancer	9.56e-05	0.00164	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Methotrexate—esophageal cancer	9.53e-05	0.000909	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TYMP—esophageal cancer	9.52e-05	0.00163	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	9.46e-05	0.00162	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	9.32e-05	0.0016	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP26A1—esophageal cancer	9.26e-05	0.00159	CbGpPWpGaD
Hydroxyurea—Nausea—Capecitabine—esophageal cancer	9.23e-05	0.00088	CcSEcCtD
Hydroxyurea—Body temperature increased—Methotrexate—esophageal cancer	9.14e-05	0.000872	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GNG7—esophageal cancer	9.09e-05	0.00156	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ALOX15—esophageal cancer	9.02e-05	0.00155	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—TPI1—esophageal cancer	8.61e-05	0.00148	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTO1—esophageal cancer	8.61e-05	0.00148	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Methotrexate—esophageal cancer	8.52e-05	0.000813	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ALDH2—esophageal cancer	8.52e-05	0.00146	CbGpPWpGaD
Hydroxyurea—Asthenia—Methotrexate—esophageal cancer	8.3e-05	0.000791	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ALDOB—esophageal cancer	8.25e-05	0.00142	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTT1—esophageal cancer	8.11e-05	0.00139	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2A6—esophageal cancer	8.01e-05	0.00137	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GAPDH—esophageal cancer	7.94e-05	0.00136	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Methotrexate—esophageal cancer	7.92e-05	0.000755	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CRABP1—esophageal cancer	7.87e-05	0.00135	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	7.82e-05	0.00134	CbGpPWpGaD
Hydroxyurea—Dizziness—Methotrexate—esophageal cancer	7.65e-05	0.000729	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PTGS1—esophageal cancer	7.6e-05	0.0013	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ENO1—esophageal cancer	7.6e-05	0.0013	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RB1—esophageal cancer	7.59e-05	0.0013	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GNG7—esophageal cancer	7.49e-05	0.00128	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PSME2—esophageal cancer	7.48e-05	0.00128	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PSME1—esophageal cancer	7.48e-05	0.00128	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	7.44e-05	0.00128	CbGpPWpGaD
Hydroxyurea—Vomiting—Methotrexate—esophageal cancer	7.36e-05	0.000701	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	7.35e-05	0.00126	CbGpPWpGaD
Hydroxyurea—Rash—Methotrexate—esophageal cancer	7.29e-05	0.000695	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—esophageal cancer	7.29e-05	0.000695	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—esophageal cancer	7.25e-05	0.000691	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ALDH2—esophageal cancer	7.02e-05	0.0012	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	6.97e-05	0.0012	CbGpPWpGaD
Hydroxyurea—Nausea—Methotrexate—esophageal cancer	6.87e-05	0.000655	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—RB1—esophageal cancer	6.79e-05	0.00116	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTT1—esophageal cancer	6.67e-05	0.00115	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	6.67e-05	0.00114	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP2A6—esophageal cancer	6.6e-05	0.00113	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP1B1—esophageal cancer	6.46e-05	0.00111	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ENO1—esophageal cancer	6.25e-05	0.00107	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS1—esophageal cancer	6.25e-05	0.00107	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PSME2—esophageal cancer	6.16e-05	0.00106	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PSME1—esophageal cancer	6.16e-05	0.00106	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP19A1—esophageal cancer	6.07e-05	0.00104	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—esophageal cancer	5.97e-05	0.00102	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	5.93e-05	0.00102	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	5.84e-05	0.001	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—esophageal cancer	5.64e-05	0.000967	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	5.57e-05	0.000956	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HMOX1—esophageal cancer	5.54e-05	0.000951	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	5.49e-05	0.000943	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	5.45e-05	0.000936	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ABCB1—esophageal cancer	5.32e-05	0.000912	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP1B1—esophageal cancer	5.32e-05	0.000912	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—EP300—esophageal cancer	5.19e-05	0.00089	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND1—esophageal cancer	5.04e-05	0.000865	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP19A1—esophageal cancer	5e-05	0.000858	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1A—esophageal cancer	4.88e-05	0.000837	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—EP300—esophageal cancer	4.64e-05	0.000796	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HMOX1—esophageal cancer	4.56e-05	0.000783	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—esophageal cancer	4.52e-05	0.000776	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ABCB1—esophageal cancer	4.38e-05	0.000751	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYC—esophageal cancer	4.04e-05	0.000694	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CREBBP—esophageal cancer	3.55e-05	0.00061	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—esophageal cancer	3.32e-05	0.00057	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NOS3—esophageal cancer	3.18e-05	0.000546	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC52A3—esophageal cancer	2.99e-05	0.000514	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—BLVRB—esophageal cancer	2.99e-05	0.000514	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CREBBP—esophageal cancer	2.93e-05	0.000502	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS2—esophageal cancer	2.91e-05	0.000499	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NOS3—esophageal cancer	2.62e-05	0.00045	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CA1—esophageal cancer	2.55e-05	0.000437	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC10A2—esophageal cancer	2.55e-05	0.000437	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—EP300—esophageal cancer	2.42e-05	0.000415	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—esophageal cancer	2.4e-05	0.000411	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CA2—esophageal cancer	2.33e-05	0.000399	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PLCE1—esophageal cancer	2.16e-05	0.000371	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ADH7—esophageal cancer	2.16e-05	0.000371	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—EP300—esophageal cancer	1.99e-05	0.000342	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ADH1B—esophageal cancer	1.9e-05	0.000326	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TYMP—esophageal cancer	1.81e-05	0.000311	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—esophageal cancer	1.79e-05	0.000307	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.76e-05	0.000303	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.72e-05	0.000295	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.64e-05	0.000281	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TPI1—esophageal cancer	1.64e-05	0.000281	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.57e-05	0.00027	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.51e-05	0.00026	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.5e-05	0.000257	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—esophageal cancer	1.47e-05	0.000253	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GNG7—esophageal cancer	1.43e-05	0.000245	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.34e-05	0.000229	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.27e-05	0.000218	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.26e-05	0.000216	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO1—esophageal cancer	1.19e-05	0.000204	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.19e-05	0.000204	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PSME1—esophageal cancer	1.17e-05	0.000201	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PSME2—esophageal cancer	1.17e-05	0.000201	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.01e-05	0.000174	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP19A1—esophageal cancer	9.53e-06	0.000163	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HMOX1—esophageal cancer	8.69e-06	0.000149	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCB1—esophageal cancer	8.34e-06	0.000143	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CREBBP—esophageal cancer	5.58e-06	9.57e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NOS3—esophageal cancer	4.99e-06	8.57e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.57e-06	7.83e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—EP300—esophageal cancer	3.8e-06	6.52e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.81e-06	4.82e-05	CbGpPWpGaD
